Samjin Pharm (005500) — Capital Reinvestment Ratio
Latest as of June 2025:
0.36x
Samjin Pharm (005500) has a Capital Reinvestment Ratio of 0.36x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.63 Billion) in capital expenditures (₩3.78 Billion). See 005500 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.36x
Capex / Operating Cash Flow
Operating Cash Flow
₩10.63 Billion
KRW
Capital Expenditures
₩3.78 Billion
KRW
Data as of
Jun 2025
Most recent filing
Samjin Pharm Capital Reinvestment Ratio (2013–2024)
This chart tracks Samjin Pharm's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Samjin Pharm (2013–2024)
Year-by-year Capital Reinvestment Ratio for Samjin Pharm from 2013 to 2024. For live market cap and broader valuation context, see market cap of Samjin Pharm.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩38.15 Billion | ₩18.34 Billion | ▼ -80.7% |
| 2023 | 2.49x | ₩8.33 Billion | ₩20.72 Billion | ▲ +21.1% |
| 2022 | 2.05x | ₩17.29 Billion | ₩35.50 Billion | ▼ -34.1% |
| 2021 | 3.11x | ₩23.97 Billion | ₩74.60 Billion | ▲ +142.7% |
| 2020 | 1.28x | ₩23.86 Billion | ₩30.60 Billion | ▲ +151.7% |
| 2019 | 0.51x | ₩23.63 Billion | ₩12.04 Billion | ▲ +86.1% |
| 2018 | 0.27x | ₩30.08 Billion | ₩8.24 Billion | ▲ +15.2% |
| 2017 | 0.24x | ₩37.28 Billion | ₩8.86 Billion | ▲ +48.3% |
| 2016 | 0.16x | ₩48.66 Billion | ₩7.80 Billion | ▼ -60.4% |
| 2015 | 0.40x | ₩18.94 Billion | ₩7.66 Billion | ▼ -1.8% |
| 2014 | 0.41x | ₩32.41 Billion | ₩13.35 Billion | ▼ -55.5% |
| 2013 | 0.93x | ₩7.37 Billion | ₩6.83 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow